ES2088024T3 - Sistema de formulacion de lipidos. - Google Patents

Sistema de formulacion de lipidos.

Info

Publication number
ES2088024T3
ES2088024T3 ES91919389T ES91919389T ES2088024T3 ES 2088024 T3 ES2088024 T3 ES 2088024T3 ES 91919389 T ES91919389 T ES 91919389T ES 91919389 T ES91919389 T ES 91919389T ES 2088024 T3 ES2088024 T3 ES 2088024T3
Authority
ES
Spain
Prior art keywords
vaginal
matrix
lipid
particles
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919389T
Other languages
English (en)
Inventor
Bengt Herslof
Martin Nicklasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2088024T3 publication Critical patent/ES2088024T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fertilizers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON UNA MATRIZ DE FORMACION DE PARTICULAS DE LIPIDOS, CARACTERIZADA EN TANTO QUE A PARTIR DE UN SISTEMA DEFINIDO DE, AL MENOS, DOS COMPONENTES LIPIDICOS SELECCIONADOS DE CLASES DE DISTINTA POLARIDAD, EN EL QUE, AL MENOS, UNO DE LOS COMPONENTES LIPIDICOS FORMA CAPAS DOBLES, SE FORMAN PARTICULAS DISCONTINUAS DE LIPIDOS DE FORMA ESPONTANEA CUANDO INTERACTUAN CON SISTEMAS ACUOSOS. PREFERIBLEMENTE, AL MENOS UNO DE LOS COMPONENTES LIPIDICOS ES ANFIFATICO Y POLAR Y UNO ES NO POLAR. ESTAS PARTICULAS DISCONTINUAS SE FORMAN ESPONTANEAMENTE A PARTIR DE LA MATRIZ SIN NINGUN TRATAMIENTO NI INICIACION QUIMICO/A NI FISICO/A. LA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS PUEDE CONTENER MATERIALES BIOACTIVOS, SELECCIONADOS DEL GRUPO DE MEDICAMENTOS, HERBICIDAS, PESTICIDAS, FERTILIZANTES, INGREDIENTES O ADITIVOS ALIMENTARIOS O COSMETICOS. LA INVENCION TAMBIEN ESTA RELACIONADA CON UN PROCESO PARA LA PRODUCCION DE LA MATRIZ, EL USO DE LA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS COMOSISTEMA PORTADOR PARA MATERIALES BIOACTIVOS Y COMPOSICIONES FARMACEUTICAS TALES COMO VEHICULOS ORALES, RECTALES, NASALES, VAGINALES, OCULARES O PARENTERALES, CREMAS, UNGUENTOS, CAPSULAS Y COMPRIMIDOS QUE CONTIENEN DICHA MATRIZ FORMADORA DE PARTICULAS LIPIDICAS Y UN MEDICAMENTO.
ES91919389T 1990-09-28 1991-09-24 Sistema de formulacion de lipidos. Expired - Lifetime ES2088024T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system

Publications (1)

Publication Number Publication Date
ES2088024T3 true ES2088024T3 (es) 1996-08-01

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919389T Expired - Lifetime ES2088024T3 (es) 1990-09-28 1991-09-24 Sistema de formulacion de lipidos.

Country Status (15)

Country Link
EP (1) EP0514506B1 (es)
JP (1) JP2855594B2 (es)
AT (1) ATE137667T1 (es)
AU (1) AU645143B2 (es)
CA (1) CA2069760C (es)
DE (1) DE69119400T2 (es)
DK (1) DK0514506T3 (es)
ES (1) ES2088024T3 (es)
FI (1) FI107696B (es)
GR (1) GR3020674T3 (es)
IE (1) IE62194B1 (es)
NO (1) NO304729B1 (es)
PT (1) PT99113B (es)
SE (1) SE9003100D0 (es)
WO (1) WO1992005771A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
ES2158084T3 (es) * 1994-02-04 2001-09-01 Lipocore Holding Ab Preparaciones vehiculo lipofilicas.
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
EE200100342A (xx) 1998-12-23 2002-10-15 Idea Ag Parendatud ravimvorm in vivo mitteinvasiivseks paikseks rakendamiseks
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
NZ550320A (en) 2004-04-15 2010-02-26 Chiasma Inc Compositions capable of facilitating penetration across a biological barrier
AU2006240551A1 (en) * 2005-04-28 2006-11-02 Dsm Ip Assets B.V. Pharmaceutical dosage forms comprising a lipid phase
PL1933809T3 (pl) * 2005-10-11 2012-09-28 Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Kompozycje do dostarczania donosowego
RU2319506C2 (ru) * 2005-10-12 2008-03-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Способ получения носителя антигенов на основе липидов из морских макрофитов и тритерпенового гликозида кукумариозида
RU2322259C1 (ru) * 2006-06-29 2008-04-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Носитель антигенов
BRPI0918652B1 (pt) 2008-09-17 2021-10-19 Chiasma, Inc. Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
HUE071943T2 (hu) 2015-02-03 2025-10-28 Amryt Endo Inc Akromegália kezelése oktreotid orális alkalmazásával
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
AU2021444376A1 (en) * 2021-05-03 2023-11-16 Mcal Therapeutics Inc. Micronized lipids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
DE3852409T2 (de) * 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.

Also Published As

Publication number Publication date
AU645143B2 (en) 1994-01-06
PT99113A (pt) 1992-08-31
EP0514506A1 (en) 1992-11-25
IE913246A1 (en) 1992-04-08
WO1992005771A1 (en) 1992-04-16
DE69119400T2 (de) 1996-12-05
JPH05503711A (ja) 1993-06-17
ATE137667T1 (de) 1996-05-15
FI922452L (fi) 1992-05-27
DE69119400D1 (de) 1996-06-13
CA2069760C (en) 1998-02-10
NO304729B1 (no) 1999-02-08
NO922084L (no) 1992-05-26
JP2855594B2 (ja) 1999-02-10
NO922084D0 (no) 1992-05-26
CA2069760A1 (en) 1992-03-29
PT99113B (pt) 1999-02-26
SE9003100D0 (sv) 1990-09-28
FI107696B (fi) 2001-09-28
AU8710591A (en) 1992-04-28
IE62194B1 (en) 1994-12-28
EP0514506B1 (en) 1996-05-08
FI922452A0 (fi) 1992-05-27
GR3020674T3 (en) 1996-10-31
DK0514506T3 (da) 1996-08-12

Similar Documents

Publication Publication Date Title
ES2088024T3 (es) Sistema de formulacion de lipidos.
EP0701815B1 (de) Verfahren zur Herstellung von Wirkstoff enthaltenden Pulvern, Granulaten oder Pellets mit einem Gerüst aus hydrophilen Makromolekülen und ihre Verwendung
ES2081349T3 (es) Rotogranulaciones y recubrimientos para enmascarar el sabor para la preparacion de comprimidos farmaceuticos de mascar.
CH638535A5 (de) Metronidazolphosphorsaeure(salze), sowie diese enthaltende arzneimittel.
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
ES2053549T3 (es) Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
ES2131318T3 (es) Pelets.
Arora et al. A review on pharmaceutical suspension and its advancement
JP2019038801A (ja) 医薬品
BR0007428A (pt) Composições com estabilidade aprimorada
DE60109945T2 (de) IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN
Khan et al. Development of microencapsulation: A review of literature
US20050088632A1 (en) Vitasolve dissolving film strips with supplements pharmaceutical drug(RX), +vitamins
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
Fogh et al. Veratrum alkaloids in sneezing-powder a potential danger
Okafor Microencapsulation techniques in HIV pediatric formulations: advances and future outlook
WO2002002642A3 (de) Zusammensetzung für pharmaka und kosmetika
US20080274188A1 (en) Oral Vehicle For Systemic Pharmaceuticals
Sonawane et al. An Innovative Approach
WO2016090284A1 (en) Spray composition for treating and preventing diaper rash
KR970033016A (ko) 치토산과 라놀린의 혼성막으로 이루어진 캡슐 및 이의 제조방법
Widmann Extraction of Curcuma longa L. with supercritical CO2
TWM626018U (zh) 含有藻類萃取物的微粒結構
EP0524963B1 (de) Verfahren zur herstellung fester wirkstoff-formen und die so erhaltenen produkte
FI77778C (fi) Kosmetiskt medel innehaollande en dubbelemulsion och foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19931209

FG2A Definitive protection

Ref document number: 514506

Country of ref document: ES